Prompted by a recent paper by Maynard and co-workers (Maynard, A. T.; Huang, M.; Rice, W. G.; Covel, D. G. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 11578), we propose that a specific property of a chemical species, the square of its electronegativity divided by its chemical hardness, be taken as defining its electrophilicity index. We tabulate this quantity for a number of atomic and molecular species, for two different models of the energy−electron number relationships, and we show that it measures the second-order energy change of an electrophile as it is saturated with electrons.

The JUNO experiment locates in Jinji town, Kaiping city, Jiangmen city, Guangdong province. The geographic location is east longitude 112 • 31'05' and North latitude 22 • 07'05'. The experimental site is 43 km to the southwest of the Kaiping city, a county-level city in the prefecture-level city Jiangmen in Guangdong province. There are five big cities, Guangzhou, Hong Kong, Macau, Shenzhen, and Zhuhai, all in ∼200 km drive distance, as shown in figure 3.

Fluorinated organic molecules exhibit a series of unique features such as great thermal and oxidative stability, [1] elevated resistance to degradation, [2] enhanced hydrophobicity, high lipophobicity of perfluorinated substances, [3] and inverted charge density distribution in fluorinated aromatic compounds.[4] These special features are related to the unique properties of the fluorine atom:[5] a) fluorine is the most electronegative element, with a Pauling electronegativity of 4.0, which is much larger than that of hydrogen (2.2); b) fluorine is the smallest electron-withdrawing group (van der Waals radius, r = 1.35 , only slightly larger than hydrogen, r = 1.2 ). Furthermore, these fluorine atoms often have a great influence on inter-and intramolecular interactions through C-F···H, F···S, and C-F···p F interactions. [2,6] As a result, fluorinated conjugated materials have been explored for their applications in organic field-effect transistors (OFET) [7] and organic light-emitting diodes (OLED). [4,8] However, there are only a few examples of applying fluorinated compounds in organic photovoltaics, [9] especially as p-type semiconductors in bulk heterojunction (BHJ) polymer solar cells.Since the fluorine atom is a strong electron-withdrawing substituent, the introduction of F into the conjugated backbone would lower both the lowest unoccupied molecular orbital (LUMO) and highest occupied molecular orbital (HOMO) energy levels of the conjugated polymers, as demonstrated by Heeger and BrØdas in a theoretical study of poly(phenylene vinylene) having various substituents. [10] Experimentally, Yu et al. confirmed the electronic effect of the fluorine substituent in their study of a series of benzodithiophene thieno[3,4-b]thiophene copolymers.[9b] After one fluorine atom was substituted onto the thieno [3,4-b]thiophene unit, the copolymer exhibited decreased LUMO and HOMO energy levels, but with a similar band gap, as compared with those of the nonfluorinated analogue. A larger open-circuit voltage (V oc ) was observed from the BHJ device based on the F-substituted polymer, and this difference is largely because of the lower HOMO energy level. Moreover, the short-circuit current (J sc ) and the fill factor (FF) were noticeably increased by judicious selection of solvent and additives, [11] possibly because of an optimized film morphology facilitated by these F atoms. A similar enhancement on the morphology by employing F atoms was observed by Kim et al. in their study of poly(3-hexylthiophene) (P3HT) having various end-groups.[9a] The CF 3 end-group-modified P3HT showed significant improvement in both the J sc and FF values for its BHJ devices, thus leading to a 40 % increase in the efficiency (h). The much improved morphology of the polymer/PC 61 BM blend was attributed to the decreased surface energy of the fluorine-containing polymer. However, there has been no precedent study on the photovoltaic properties of F-containing low-band-gap polymers constructed using the donor-acceptor strategy, [12] which is a comm...

PURPOSE Patients with pretreated estrogen receptor (ER)–positive/human epidermal growth factor receptor 2 (HER2)–negative advanced breast cancer have poor prognosis. Elacestrant is a novel, oral selective ER degrader that demonstrated activity in early studies. METHODS This randomized, open-label, phase III trial enrolled patients with ER-positive/HER2-negative advanced breast cancer who had one-two lines of endocrine therapy, required pretreatment with a cyclin-dependent kinase 4/6 inhibitor, and ≤ 1 chemotherapy. Patients were randomly assigned to elacestrant 400 mg orally once daily or standard-of-care (SOC) endocrine monotherapy. Primary end points were progression-free survival (PFS) by blinded independent central review in all patients and patients with detectable ESR1 mutations. RESULTS Patients were randomly assigned to elacestrant (n = 239) or SOC (n = 238). ESR1 mutation was detected in 47.8% of patients, and 43.4% received two prior endocrine therapies. PFS was prolonged in all patients (hazard ratio = 0.70; 95% CI, 0.55 to 0.88; P = .002) and patients with ESR1 mutation (hazard ratio = 0.55; 95% CI, 0.39 to 0.77; P = .0005). Treatment-related grade 3/4 adverse events occurred in 7.2% receiving elacestrant and 3.1% receiving SOC. Treatment-related adverse events leading to treatment discontinuations were 3.4% in the elacestrant arm versus 0.9% in SOC. Nausea of any grade occurred in 35.0% receiving elacestrant and 18.8% receiving SOC (grade 3/4, 2.5% and 0.9%, respectively). CONCLUSION Elacestrant is the first oral selective ER degrader demonstrating a significant PFS improvement versus SOC both in the overall population and in patients with ESR1 mutations with manageable safety in a phase III trial for patients with ER-positive/HER2-negative advanced breast cancer.

No abstract

No abstract

We report an implementation of decoy-state quantum key distribution (QKD) over 200 km optical fiber cable through photon polarization encoding. This is achieved by constructing the whole QKD system operating at 320 MHz repetition rate, and developing high-speed transmitter and receiver modules. A novel and economic way of synchronization method is designed and incorporated into the system, which allows to work at a low frequency of 40kHz and removes the use of highly precise clock. A final key rate of 15 Hz is distributed within the experimental time of 3089 seconds, by using super-conducting single photon detectors. This is longest decoy-state QKD yet demonstrated up to date. It helps to make a significant step towards practical secure communication in long-distance scope.

Both core decompression with or without implantation of BMMC are effective treatment for ONFH. However, core decompression with implantation of BMMCs and porous hydroxyapatite bone filler may be a more effective treatment for ONFH.